Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2022

Mounjaro(Tirzepatide)Eli Lilly and Company logoLLY

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Eli Lilly and Company

$6.33B

Medicare cost, 2024

Medicare drug plans spent $6.3 billion on Mounjaro (tirzepatide) in 2024, for 5.1 million prescriptions and refills filled by 894,243 patients. It ranks 4th among all drugs by Medicare drug plan spending. Spending rose 168% from 2023 to 2024. It was first approved in 2022.

Medicare cost, 2024

$6.33B

+168.3% from 2023

Prescriptions

5.1M

$1,241.24 per claim

Patients

894K

194,653 prescribers

Total spending, 2024

$6.34B

$7,083.70 per patient

Questions and answers

How much does Medicare spend on Mounjaro?

Medicare prescription drug plans paid $6.33B for Mounjaro in 2024, for 5,103,556 prescriptions and refills to 894,243 patients (up 168.3% from 2023). The average cost per claim was $1,241.24.

Which state spends the most on Mounjaro?

Texas had the highest Medicare cost for Mounjaro in 2024: $624.0M for 491,789 claims, followed by Florida ($494.1M).

Who prescribes Mounjaro the most?

Shahed Quyyumi, endocrinology in Staten Island, NY, had the highest Medicare cost for Mounjaro in 2024: 1,709 claims costing $2.5M.

Who makes Mounjaro?

Mounjaro is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Mounjaro was $6.34B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Mounjaro, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Shahed Quyyumi Staten Island, NYEndocrinology1,709299$2.5M
Eugenio Angueira-Serrano Miami, FLEndocrinology1,949293$2.1M
Stella Ilyayeva Rego Park, NYInternal Medicine1,720316$2.0M
Chitharanjan Duvoor Jonesboro, AREndocrinology1,348250$1.9M
Iraklii Buziashvili Brooklyn, NYEndocrinology1,704305$1.8M
Gary Reznik Los Angeles, CACardiology1,751214$1.8M
Anastasios Manessis New York, NYEndocrinology1,281256$1.7M
Muhammad I Choudhry Weatherford, TXEndocrinology1,146249$1.6M
Najmuddin K Karimjee Houston, TXInternal Medicine1,199271$1.6M
Matthew F Kamil Concord, NHEndocrinology1,096202$1.6M
Swarna Varma Pittsburgh, PAEndocrinology1,268189$1.5M
Mohammad T Ijaz Zanesville, OHEndocrinology1,363222$1.5M
Vita Anksh Naples, FLEndocrinology1,206203$1.5M
Kalyani Regeti North Port, FLEndocrinology892170$1.4M
Joseph Terrana Nesconset, NYEndocrinology1,043170$1.4M
Wael E Eid Covington, KYEndocrinology1,084212$1.4M
Amer Issa Saginaw, MIEndocrinology1,089219$1.4M
Matin Sharafatkhah Brooklyn, NYEndocrinology1,331196$1.4M
Benjamin D Prohaska Reno, NVPhysician Assistant960169$1.4M
Rory S Breidbart New Hyde Park, NYEndocrinology1,017143$1.4M
Pamela Lopez Weslaco, TXNurse Practitioner881193$1.4M
Carla L Hudson Opelika, ALNurse Practitioner1,141192$1.3M
Monica G Robles Anniston, ALEndocrinology850188$1.3M
Robert M Oberstein Hartford, CTEndocrinology986148$1.3M
Leila Chaychi San Carlos, CAEndocrinology957167$1.3M

Prescriber data by year

YearPrescribersClaimsPatientsCost
202230,007121,05054,187$144.0M
2023118,8601,820,883370,074$2.36B
2024194,6535,103,556894,243$6.33B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Eli Lilly & Co.LLY logoLLY5,105,397$6.34B

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
25
RxNorm concept IDs
2601743, 2601746, 2601755, 2601758, 2601761
Application numbers
NDA215866

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube